IL6 and type 2 diabetes mellitus: The pathophysiology of diabetes mellitus resembles a state of chronic inflammation, with elevated levels of inflammatory cytokines such as interleukin-6 (IL-6) and tumor necrosis factor-α (TNF-α) in patients with type 2 diabetes.